Patients Suffer as Dea Unexplained Delays MMJ’s Marijuana Research, Clinical Trials, and Pharmaceutical Development
![Patients Suffer as Dea Unexplained Delays MMJ’s Marijuana Research, Clinical Trials, and Pharmaceutical Development](https://www.cannabisindustry.news/wp-content/uploads/2022/09/c54cd512-1359-533c-afab-c40f6ba0f798-850x560.png)
PROVIDENCE, RI / ACCESSWIRE / September 6, 2022 / Duane Boise, MMJ companies President echoing the NIH directors recent statements remarked, “Unfortunately MMJ was forced to file suit against the DEA…